Request A Free Consultation
Arizona panorama with cacti

Cymbalta Users Beware

July 21, 2015 Hastings and Hastings

In August of 2004, the FDA approved of the drug Cymbalta to treat depression. Cymbalta is a serotonin-norepinephrine reuptake inhibitor (SNRI) which functions by managing certain brain chemical associated with mental stability. The drug was later found to treat other conditions such as: anxiety, muscle pain, urinary incontinence, stress, and even diabetic neuropathy. The drug was so effective that it made its progenitors $5 billion dollars its first year. Unfortunately, the side effects of Cymbalta are extremely troubling, painful, and deleterious to the physical health and soul of the individual.

The withdrawal symptom of Cymbalta include the following: nausea, dizziness, headaches, vomiting, brain zap—an electric-shock sensation in the brain. It is well known that these symptoms will manifest after abruptly stopping SNRI antidepressants. The medical community refers to this as Antidepressant Discontinuation Syndrome. But it seems that the withdrawal symptoms associated with Cymbalta are more severe than Cymbalta. What’s more, users claim that the drug Cymbalta allegedly fails to warn customers about all the risks associated with taking the drug, and for that, a class action law suit will ensue.

The first Cymbalta lawsuit came in October 2012, and since then, hundreds of other law suits have followed.  Indeed, the pattern of pharmaceutical drugs hitting the market, causing significant damage to the users, and then settling for a class action lawsuit, has become the norm. This pattern is part of a vicious cycle of law suits, settlements, and ferocious lobbying.

Indeed, America is an extremely litigious society. It is indeed a catch twenty-two. Excessive litigation is accepted in exchange for limited government and personal freedom. One might ask themselves what is more important: in the words of Shakespeare, “killing all the lawyers,”, or enjoying liberty—the souls right to breathe.